Compare FUNC & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FUNC | PROF |
|---|---|---|
| Founded | 1900 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.0M | 248.8M |
| IPO Year | 2012 | 2017 |
| Metric | FUNC | PROF |
|---|---|---|
| Price | $44.39 | $6.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $50.00 | $11.14 |
| AVG Volume (30 Days) | 33.3K | ★ 260.9K |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.55% | N/A |
| EPS Growth | 19.68 | ★ 25.89 |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $18,426,000.00 | $16,098,000.00 |
| Revenue This Year | $9.57 | $71.10 |
| Revenue Next Year | $6.10 | $58.54 |
| P/E Ratio | $23.12 | ★ N/A |
| Revenue Growth | 4.01 | ★ 50.73 |
| 52 Week Low | $33.54 | $4.91 |
| 52 Week High | $46.30 | $8.95 |
| Indicator | FUNC | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 53.10 | 45.68 |
| Support Level | $43.77 | $5.74 |
| Resistance Level | $45.71 | $6.23 |
| Average True Range (ATR) | 1.23 | 0.42 |
| MACD | 0.07 | 0.05 |
| Stochastic Oscillator | 53.70 | 22.86 |
First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.